HYTN Innovations, Inc.

Market Cap: Micro Cap
Industry: Pharmaceuticals & Biotechnology
ISIN: CA40443L1040

CAD

0.10

-0.07 (-42.86%)

Dec 04

CNQ

Click here to see other stocks

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.Unlock 29 Markets

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Rubicon Organics, Inc.

Juva Life, Inc. (British Columbia)

IM Cannabis Corp.

Simply Better Brands Corp.

HYTN Innovations, Inc.

Adastra Holdings Ltd.

BioNxt Solutions, Inc.

Blueberries Medical Corp.

Predictmedix AI, Inc.

Captor Capital Corp.

Promino Nutritional Sciences, Inc.

Why is HYTN Innovations, Inc. ?

Flat results in Jun 24

ROCE(HY) Lowest at -426.38%

Risky - Negative EBITDA

The stock is trading risky as compared to its average historical valuations
Over the past year, while the stock has generated a return of -33.33%, its profits have fallen by -184.6%

Below par performance in long term as well as near term

Along with generating -33.33% returns in the last 1 year, the stock has also underperformed S&P/TSX 60 in the last 3 years, 1 year and 3 months

Real-Time Research Report

Verdict Report

How much should you sell?

All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is HYTN Innovations, Inc. for you?

High Risk, Low Return

Absolute

Risk Adjusted

Volatility

HYTN Innovations, Inc.

-100.0%

-0.49

122.95%

S&P/TSX 60

19.1%

1.43

14.72%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

17.92%

EBIT Growth (5y)

-210.53%

EBIT to Interest (avg)

-1.76

Debt to EBITDA (avg)

Negative Net Debt

Net Debt to Equity (avg)

Sales to Capital Employed (avg)

-0.08

Tax Ratio

Dividend Payout Ratio

Pledged Shares

Institutional Holding

ROCE (avg)

ROE (avg)

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

NA (Loss Making)

Industry P/E

Price to Book Value

-15.02

EV to EBIT

-5.42

EV to EBITDA

-6.04

EV to Capital Employed

-15.24

EV to Sales

11.90

PEG Ratio

Dividend Yield

ROCE (Latest)

Negative Capital Employed

ROE (Latest)

Negative BV

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Bearish

RSI

No Signal

Bollinger Bands

Mildly Bearish

Moving Averages

Bearish (Daily)

KST

Bearish

Bullish

Dow Theory

No Trend

OBV

No Trend

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

Not enough Data to analyse Financial Trend

Here's what is working for HYTN Innovations, Inc.

Net Sales

At CAD 0.54 MM has Grown at 60.58%

Year on Year (YoY)

MOJO Watch

Near term sales trend is positive

Net Sales (CAD MM)

Net Profit

Higher at CAD -0.77 MM

than preceding 12 month period ended Jun 2024

MOJO Watch

In the half year the company has already crossed Net Profit of the previous twelve months

Net Profit (CAD MM)

Raw Material Cost

Fallen by -83.66% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales